loader
Please Wait
Applying Filters...

Athena Athena

X

List of Drug Master Files (DMF) for 26043 Active Pharmaceutical Ingredient (API) submitted to the U.S. FDA. Original Data : FDA Website

Client Virtual Booth
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 Chongqing Shenghuaxi Pharma. Co., Ltd (1)

filter

01 FEBUXOSTAT (1)

filter

01 China (1)

filter

01 Active (1)

filter

01 Complete (1)

URL Supplier Web Content
26043
Active
2013-01-31
Complete
2013-06-25
2013-02-01
II
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for Drug Master Files (DMF) for 26043 of Chongqing Shenghuaxi Pharmaceutical Co Ltd

Looking for Drug Master Files (DMF) for 26043 of Chongqing Shenghuaxi Pharmaceutical Co Ltd 1

20

Chongqing Shenghuaxi Pharmaceutical Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA.

One of their notable products is FEBUXOSTAT, with a corresponding US DMF Number 26043.

Remarkably, this DMF maintains an Active status since its submission on January 31, 2013, highlighting commitment to regulatory compliance.

Their GDUFA DMF Review was successfully complete, with a review date of June 25, 2013, and payment made on February 01, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II

Post Enquiry
POST ENQUIRY